Sorrento Therapeutics, Inc.

Delisted

CIK 850261fmd_1K2S4Q2ABT1BTXA8ZW5E3A4SMFManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2007 to Jun 30, 2023, 56 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.